Suppr超能文献

神经元蜡样脂褐质沉积症在分子水平上存在关联:CLN5蛋白与CLN2和CLN3的相互作用。

Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3.

作者信息

Vesa Jouni, Chin Mark H, Oelgeschläger Kathrin, Isosomppi Juha, DellAngelica Esteban C, Jalanko Anu, Peltonen Leena

机构信息

Department of Human Genetics, University of California at Los Angeles School of Medicine, Gonda Neuroscience and Genetics Research Center, Los Angeles, California 90095-7088, USA.

出版信息

Mol Biol Cell. 2002 Jul;13(7):2410-20. doi: 10.1091/mbc.e02-01-0031.

Abstract

Neuronal ceroid lipofuscinoses (NCLs) are neurodegenerative storage diseases characterized by mental retardation, visual failure, and brain atrophy as well as accumulation of storage material in multiple cell types. The diseases are caused by mutations in the ubiquitously expressed genes, of which six are known. Herein, we report that three NCL disease forms with similar tissue pathology are connected at the molecular level: CLN5 polypeptides directly interact with the CLN2 and CLN3 proteins based on coimmunoprecipitation and in vitro binding assays. Furthermore, disease mutations in CLN5 abolished interaction with CLN2, while not affecting association with CLN3. The molecular characterization of CLN5 revealed that it was synthesized as four precursor forms, due to usage of alternative initiator methionines in translation. All forms were targeted to lysosomes and the longest form, translated from the first potential methionine, was associated with membranes. Interactions between CLN polypeptides were shown to occur with this longest, membrane-bound form of CLN5. Both intracellular targeting and posttranslational glycosylation of the polypeptides carrying human disease mutations were similar to wild-type CLN5.

摘要

神经元蜡样脂褐质沉积症(NCLs)是一类神经退行性贮积病,其特征为智力发育迟缓、视力衰退、脑萎缩以及多种细胞类型中出现贮积物质的积累。这些疾病由普遍表达的基因突变引起,其中已知的有六种。在此,我们报告三种具有相似组织病理学特征的NCL疾病形式在分子水平上存在关联:基于免疫共沉淀和体外结合试验,CLN5多肽与CLN2和CLN3蛋白直接相互作用。此外,CLN5中的疾病突变消除了与CLN2的相互作用,而不影响与CLN3的结合。CLN5的分子特征表明,由于翻译过程中使用了不同的起始甲硫氨酸,它以四种前体形式合成。所有形式都靶向溶酶体,从第一个潜在甲硫氨酸翻译而来的最长形式与膜相关。CLN多肽之间的相互作用显示发生在这种最长的、与膜结合的CLN5形式上。携带人类疾病突变的多肽的细胞内靶向和翻译后糖基化与野生型CLN5相似。

相似文献

2
Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
Hum Mutat. 1999;14(3):199-215. doi: 10.1002/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A.
3
Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency.
Mol Genet Metab. 2006 Nov;89(3):245-53. doi: 10.1016/j.ymgme.2006.04.010. Epub 2006 Jun 30.
4
Biochemistry of neuronal ceroid lipofuscinoses.
Adv Genet. 2001;45:93-106. doi: 10.1016/s0065-2660(01)45005-x.
7
Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain.
Exp Mol Pathol. 2014 Dec;97(3):484-91. doi: 10.1016/j.yexmp.2014.10.003. Epub 2014 Oct 7.
8
Mouse gene knockout models for the CLN2 and CLN3 forms of ceroid lipofuscinosis.
Eur J Paediatr Neurol. 2001;5 Suppl A:109-14. doi: 10.1053/ejpn.2000.0445.
9
The molecular genetic basis of the neuronal ceroid lipofuscinoses.
Neurol Sci. 2000;21(3 Suppl):S15-9. doi: 10.1007/s100720070035.
10
The genetic spectrum of human neuronal ceroid-lipofuscinoses.
Brain Pathol. 2004 Jan;14(1):70-6. doi: 10.1111/j.1750-3639.2004.tb00500.x.

引用本文的文献

3
The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses.
Front Neurol. 2021 Oct 18;12:754045. doi: 10.3389/fneur.2021.754045. eCollection 2021.
4
Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype.
EMBO Mol Med. 2021 Oct 7;13(10):e13742. doi: 10.15252/emmm.202013742. Epub 2021 Aug 19.
5
A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.
Cell Mol Life Sci. 2021 May;78(10):4735-4763. doi: 10.1007/s00018-021-03813-x. Epub 2021 Apr 1.
6
Knockdown of CLN5 inhibits the tumorigenic properties of glioblastoma cells via the Akt/mTOR signaling pathway.
Oncol Lett. 2021 May;21(5):387. doi: 10.3892/ol.2021.12648. Epub 2021 Mar 17.
7
Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.
AJNR Am J Neuroradiol. 2020 Oct;41(10):1930-1936. doi: 10.3174/ajnr.A6726. Epub 2020 Aug 27.

本文引用的文献

1
Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein.
Hum Mol Genet. 2002 Apr 15;11(8):885-91. doi: 10.1093/hmg/11.8.885.
3
Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs).
Eur J Biochem. 2001 Nov;268(22):5851-6. doi: 10.1046/j.0014-2956.2001.02530.x.
5
7
CLN-encoded proteins do not interact with each other.
Neurogenetics. 2000 Sep;3(1):41-4. doi: 10.1007/pl00022978.
8
The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.
J Biol Chem. 2001 Jan 19;276(3):2249-55. doi: 10.1074/jbc.M008562200. Epub 2000 Oct 27.
10
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum.
Hum Mol Genet. 2000 Jul 1;9(11):1691-7. doi: 10.1093/hmg/9.11.1691.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验